Browsing by Author Bondarenko, I.


Showing results 1 to 3 of 3
Issue Year Title Author(s) Type Views Downloads
2022 Atezolizumab (atezo) vs best supportive care (BSC) in stage II-IIIA NSCLC with high PD-L1 expression: Sub-analysis from the pivotal phase III IMpower010 study Felip, E.; Altorki, N.K.; Zhou, C.; Vallieres, E.; Vynnychenko, Ihor Oleksandrovych; Akopov, A.; Martinez-Marti, A.; Chella, A.; Bondarenko, I.; Ursol, G.; Levchenko, E.; Kislov, N.; Liersch, R.; Belleli, R.; McNally, V.A.; Bennett, E.; Gitlitz, B.J.; Wakelee, H. Conference Papers 2198930 3564910
2022 Evaluating Alternative Ramucirumab Doses as a Single Agent or with Paclitaxel in Second-Line Treatment of Locally Advanced or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma: Results from Two Randomized, Open-Label, Phase II Studies Shah, M.A.; Udrea, A.A.; Bondarenko, I.; Mansoor, W.; Sánchez, R.G.; Sarosiek, T.; Bozzarelli, S.; Schenker, M.; Gomez-Martin, C.; Morgan, C.; Özgüroğlu, M.; Pikiel, J.; Kalofonos, H.P.; Wojcik, E.; Buchler, T.; Swinson, D.; Cicin, I.; Joseph, M.; Vynnychenko, Ihor Oleksandrovych; Luft, A.V.; Enzinger, P.C.; Salek, T.; Papandreou, C.; Tournigand, C.; Maiello, E.; Wei, R.; Ferry, D.; Gao, L.; Oliveira, J.M.; Ajani, J.A. Article 49647 27812
2021 Subsequent therapy following pembrolizumab + axitinib or sunitinib treatment for advanced renal cell carcinoma (RCC) in the phase III KEYNOTE-426 study Gafanov, R.; Powles, T.B.; Bedke, J.; Stus, V.; Waddell, T.S.; Nosov, D.; Pouliot, F.; Soulieres, D.; Melichar, B.; Azevedo, S.; McDermott, R.S.; Vynnychenko, Ihor Oleksandrovych; Borchiellini, D.; Markus, M.; Bondarenko, I.; Lin, J.; Burgents, J.; Molife, L.R.; Plimack, E.R.; Rini, B. Conference Papers 3314173 3196871